Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.54 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2659317 | 0.90 | LMNA (0.60) | LMNAHPGDTSHRLOXL2HIF1A | |
| SCHEMBL1408485 | 0.89 | CA12 (0.56) | LMNAHPGDTSHRLOXL2HIF1A | |
| SCHEMBL2069334 | 0.88 | LOXL2 (0.68) | LMNAHPGDTSHRLOXL2HIF1A | |
| SCHEMBL6158387 | 0.85 | TSHR (0.67) | LMNAHPGDTSHRLOXL2CYP4F2 | |
| SCHEMBL23120562 | 0.82 | ATM (0.53) | LMNAHPGDTSHRLOXL2HIF1A | |
| SCHEMBL15366480 | 0.81 | LMNA (0.54) | LMNAHPGDTSHRLOXL2HIF1A | |
| SCHEMBL16143289 | 0.80 | HPGD (0.52) | LMNAHPGDTSHRLOXL2CA1 | |
| SCHEMBL19039710 | 0.79 | GAA (0.53) | LMNAHPGDTSHRLOXL2CYP4F2 | |
| SCHEMBL14505830 | 0.79 | HPGD (0.63) | LMNAHPGDTSHRLOXL2HIF1A | |
| SCHEMBL2142442 | 0.79 | PLA2G10 (0.53) | LMNATSHRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110317230-B | Phosphate derivatives and use thereof | 上海昇悦医药科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| WO-2019184866-A1 | PHOSPHATE DERIVATIVES AND USE THEREOF | 朱青 | 2019-10-03 | — | — | WO | disclosed |
| US-8147036-B2 | Polyfunctional epoxy compound, epoxy resin, cationic photopolymerizable epoxy resin composition, micro structured member, producing method therefor and liquid discharge head | CANON KABUSHIKI KAISHA (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20100271428-A1 | POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD | CANON KABUSHIKI KAISHA (JP) | 2010-10-28 | — | — | US | disclosed |
| WO-2007148822-A1 | POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD | CANON KABUSHIKI KAISHA (JP) | 2007-12-27 | — | — | WO | disclosed |
| EP-1319646-B1 | PROCESS FOR PREPARATION OF 3,5-BISALKYLPHENOLS | KOWA CO (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-6806395-B2 | FOR PRODUCING 3,5- DIISOPROPYLPHENOL OR A SIMILAR COMPOUND, WHICH SERVES AS AN INTERMEDIATE FOR PRODUCING ANTI-INFLAMMATORY AGENTS, PESTICIDES, ETC. | KOWA CO., LTD. (JP) | 2004-10-19 | — | — | US | disclosed |
| US-20040044255-A1 | Process for preparation of 3,5-bisalkylphenols | KOWA CO., LTD. (JP) | 2004-03-04 | — | — | US | disclosed |
| EP-1319646-A1 | PROCESS FOR PREPARATION OF 3,5-BISALKYLPHENOLS | Kowa Co., Ltd. (JP) | 2003-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044255-A1 | Process for preparation of 3,5-bisalkylphenols | ACSL3, HACL2, ARL1 | LMNA 2714/4885HPGD 4105/4885TSHR 3117/4885 |
| US-20100271428-A1 | POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD | RER1, PNN, TIPRL | LMNA 2168/4885HPGD 1028/4885TSHR 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.